Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology, and is joined as an investment partner by Eos Advisory.
Penrhos Bio has secured the second tranche of its £1m Seed funding round, and is pleased to welcome Eos Advisory as investment partners. This investment, including the first tranche in 2021, takes the business through to its Series A raise in 2023, and accelerates our business development pipeline.
for the press release see:
Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials…
Penrhos Bio is currently undertaking a Series A investment raise. This investment will accelerate our regulatory roadmap for the Remora™ technology and unlocks a number of higher value markets such as marine fouling and human healthcare…
Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials…
Thanks to our Partners in Earthbound Brands, Remora™ becomes our brand name, logo and the face of Penrhos Bio. Supported by the ‘Cleaner by Nature’ tagline, the new Remora name will flow though onto products in our customers hands…
Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology and is joined as an investment partner by Eos Advisory…
Penrhos Bio has become a member of the National Biofilms Innovation Centre, a world leading Innovation Knowledge Centre connecting scientists and industrial partners specialising in Biofilms from across the UK…